ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BOC Sciences 2022 Free Webinar: Viral RNA Modifications and Implications for Novel Therapeutics

By: Get News
BOC Sciences grandly announced the schedule of a free webinar on September 19th, 2022, at 11:00 EDT, which is a laudable event centering on the hot spot of RNA research during the pandemic.

New York, USA – September 2, 2022 – BOC Sciences is an expert in RNA technologies. It is now renowned as the largest manufacturer of pseudoUridine and its derivatives, the critical materials for RNA modification. BOC Sciences’ annual production capacity of pseudoUridines and N1-MethylpseudoUridines exceeds 500 kg and 1,000 kg respectively, confirming its well-deserved top position among competitors.

September 19th, 11:00 EDT, BOC Sciences will join hands with Dr. David Courtney from Queen’s University Belfast, School of Medicine, Dentistry and Biomedical Sciences and introduce the blockbuster webinar: Viral RNA Modifications and Implications for Novel Therapeutics.

Since Dr. David and his lab have specialized in research on influenza viruses for several years, they obtain very fruitful findings to be shared in the webinar. In particular, Dr. David would like to present his insightful ideas about the role of RNA modifications in viral replication, specifically the influenza A virus, and how it might inform the design of both novel antivirals and mRNA-based therapeutics. This webinar will undoubtedly bring enlightenment to the research peers or industrial decision-makers who are involved in the R&D of RNA therapeutics.

BOC Sciences and Dr. David Summarized 4 Highlights of the Upcoming Webinar:

* Identify which RNA modifications are important for viral replication
* Reveal how m6A affects influenza virus replication
* Discuss how viral RNAs are modified
* Present how RNA modifications might inform future therapeutics

All above are to be addressed within the 1-hour online meeting while a brief Q&A session will follow to clear the doubts of listeners regarding the presentation. Anyone interested in this topic, whether they are students, researchers, managers, etc., are welcome to participate. It’s completely free since BOC Sciences, with a strong sense of social responsibility, holds the vision to enhance communication and inspire innovation via a series of meaningful events.

BOC Sciences opened the registration channel online a few days ago. The audience can register at https://www.bocsci.com/webinar-viral-rna-modifications-and-implications-for-novel-therapeutics.html. Just fill in the required fields of Name, Email, Phone, Organization, and Job Title. Then wait for the notification email where a link to the zoom meeting will be sent. BOC Sciences’ IT team has made much effort to simplify the procedures and save time for registrants.

“All preparatory work has been accomplished. And now we are expecting your attendance to broaden our scientific community,” the business development manager of BOC Sciences sincerely sent out invitations.

About

BOC Sciences has been engaged in RNA-related research and development for years. It produces guaranteed pseudoUridines and derivatives for both academic institutions and pharmaceutical companies, playing a crucial role in the global combat against COVID-19, especially in the creation of efficient mRNA vaccines.

Media Contact
Company Name: BOC Sciences
Contact Person: Alex Brown
Email: Send Email
Phone: 1-631-485-4226
Country: United States
Website: https://www.bocsci.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.